Parallel design in groups [Design Issues]

posted by rana – India, 2013-07-03 14:41 (4734 d 21:33 ago) – Posting: # 10925
Views: 4,003

Dear all,
Good afternoon.
Does US FDA accepts two groups seperated by time period in parallel design i.e, if study is planned with a sample size of 120 subjects in parallel design, initially study was planned with 60 subjects (group-1) and after one month gap study was planned with 60 subjects (group-2)?.
As per USFDA Guidance for Industry, Statistical Approaches to Establishing Bioequivalence, 2001 section VII A, crossover study can be carried out in two or more groups of subjects. Does this criteria can be followed for parallel design studies?
Regards,
Rana.

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
143 visitors (0 registered, 143 guests [including 30 identified bots]).
Forum time: 12:14 CEST (Europe/Vienna)

I have finally come to the konklusion
that a good reliable set ov bowels
iz worth more to a man
than enny quantity of brains.    Josh Billings

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5